Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most ...

Scalp psoriasis usually causes patches of white scales and flaky skin to form on the scalp, often behind the ears. Flare-ups of psoriasis symptoms can be unpredictable, though there are some ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

People with darker skin are more likely to find psoriasis lesions on the scalp, elbows, knees, torso, buttocks, and even nails. Affected areas can also vary in size. If you have scalp psoriasis ...

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

An expert discusses how the VISIBLE study examined comorbidity burden in moderate to severe psoriasis across all skin tones, addressing disparities in research. It aimed to highlight unmet needs and ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

score of 0/1 (clear or almost clear skin) with at least a 2-grade improvement from baseline to week 16, and the percentage of participants achieving Psoriasis Area and Severity Index (PASI ...